☆ 4.6 Meeting Abstract

Long-Term OS for Patients With Advanced NSCLC Enrolled in the KEYNOTE-001 Study of Pembrolizumab

JOURNAL OF THORACIC ONCOLOGY (2016)

Journal

JOURNAL OF THORACIC ONCOLOGY

Volume 11, Issue 10, Pages S241-S242

Publisher

ELSEVIER SCIENCE INC

DOI: 10.1016/j.jtho.2016.08.110

Keywords

advanced non-small cell lung cancer; PD-1 inhibition; pembrolizumab; PD-L1

Categories

Oncology Respiratory System

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.